LCM
LUMO

Landscape Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Landscape Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,567
Closed -$505K – 1072
2015
Q3 		$505K Buy
1,567
+11
+0.7% +$4.83K 0.07% 322
2015
Q2 		$620K Buy
+1,556
New +$661K 0.11% 255

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Landscape Capital Management's LUMO Position: Q4 2015 in Review

Landscape Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2015, closing a stake of 1,567 shares — an estimated $505K sold.

Landscape Capital Management first reported a position in LUMO in Q2 2015 and held it in 2 quarters. The position peaked at $620K in Q2 2015. 152 funds tracked by Wall St. Rank hold LUMO as of Q4 2015.

  • Landscape Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Landscape Capital Management sold 1,567 Lumos Pharma, Inc. Common Stock shares in Q4 2015, an estimated $505K.
  • Landscape Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • Landscape Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $620K in Q2 2015.
  • 152 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2015.

Based on Landscape Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.